Antigenotoxic Potential of Punica granatum in Breast Cancer Patients
No Thumbnail Available
Date
2016
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Cancer is a disease that knows no geographic boundaries. Despite decades of basic and
finical research and trials of promising new therapies, cancer remains a major cause of
jrbidity and mortality. The post genomic era has now opened new avenues in cancer treatment,
vhich is contemplated to be more effective and specific for tumor cells using various methods
uailablefor the assessment ofDNA damage and repair in cancer patients such as the bacterial
\mes test, the scoring of chromosome aberration (CA), micronuclei and sister chromatid
Exchange (SCE) in proliferating cell populations although the frequency of cells with structural
iromosomal aberrations in peripheral blood lymphocytes is the first biomarker for
rotoxicity that shows an association with overall cancer risk. The present investigation
icompasses Single Cell Gel Electrophoresis (SCGE)/Comet assay as an alternative for
{togenetic test to assess the extent ofDNA damage in breast cancer patients undergoing
ferent modalities of treatment viz., chemotherapy, chemotherapy + surgery, chemotherapy
Ifadiotherapy and chemotherapy + surgery + radiotherapy. The present study also comprises
• reduction in chromosomal damage by the addition of pomegranate extracts to peripheral
ood lymphocyte culture as a biomarker tool for DNA repair capacity of test substance.
?refore, the DNA repair capacity of Pomegranate Fruit Extract (PEE) in cultures of human
ripheral blood lymphocytes of breast cancer patients was examined.